Intervention
Patient Monitoring
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownTesting Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialNCT07200830 · 2026-03-31
RECRUITINGComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramNCT06265285 · 2024-04-30
RECRUITINGTesting the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenNCT03834571 · 2022-05-31
WITHDRAWNRemote Monitoring in Cancer Care: A Platform StudyNCT05018208 · 2021-12-15
COMPLETEDRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNCT04501913 · 2019-12-24
COMPLETEDCommon conditions
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v82Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v82Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v82Malignant Digestive System Neoplasm2Malignant Solid Neoplasm2Stage III Renal Cell Cancer AJCC v82Stage IV Colorectal Cancer AJCC v82Stage IV Renal Cell Cancer AJCC v82Stage IVB Prostate Cancer AJCC v82Advanced Esophageal Squamous Cell Carcinoma1Advanced Renal Cell Carcinoma1Cervical Adenocarcinoma1Cervical Adenosquamous Carcinoma1Cervical Squamous Cell Carcinoma, Not Otherwise Specified1Clinical Stage 0 Esophageal Adenocarcinoma AJCC v81Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v81Clinical Stage 0 Gastric Cancer AJCC v81Clinical Stage I Esophageal Adenocarcinoma AJCC v81Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v81Clinical Stage I Gastric Cancer AJCC v81Clinical Stage II Esophageal Adenocarcinoma AJCC v81Clinical Stage II Gastric Cancer AJCC v81Clinical Stage IIA Esophageal Adenocarcinoma AJCC v81Clinical Stage IIA Gastric Cancer AJCC v81Clinical Stage IIB Cutaneous Melanoma AJCC v81
Leading sponsors
Trial status mix
COMPLETED2
RECRUITING2
WITHDRAWN1
Phase mix
PHASE22
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.